Usefulness of High Sensitivity Cardiac Troponin T for the Identification of Outlier Patients with Diffuse Coronary Atherosclerosis and Low Risk Factors

Abstract Novel high sensitivity assay can detect very low levels of circulating cardiac troponin (hs-cTnT) in apparently healthy individuals. Within normal range, higher levels are associated with coronary atherosclerotic disease (CAD) and cardiac abnormalities commonly associated to traditional ris...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2016-05, Vol.117 (9), p.1397-1404
Hauptverfasser: Magnoni, Marco, MD, Masson, Serge, PhD, Andreini, Daniele, MD, Moccetti, Tiziano, MD, Modena, Maria Grazia, MD, Canestrari, Mauro, MD, Berti, Sergio, MD, Casolo, Giancarlo, MD, Gabrielli, Domenico, MD, Marraccini, Paolo, MD, Pontone, Gianluca, MD, Latini, Roberto, MD, Maggioni, Aldo Pietro, MD, Maseri, Attilio, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1404
container_issue 9
container_start_page 1397
container_title The American journal of cardiology
container_volume 117
creator Magnoni, Marco, MD
Masson, Serge, PhD
Andreini, Daniele, MD
Moccetti, Tiziano, MD
Modena, Maria Grazia, MD
Canestrari, Mauro, MD
Berti, Sergio, MD
Casolo, Giancarlo, MD
Gabrielli, Domenico, MD
Marraccini, Paolo, MD
Pontone, Gianluca, MD
Latini, Roberto, MD
Maggioni, Aldo Pietro, MD
Maseri, Attilio, MD
description Abstract Novel high sensitivity assay can detect very low levels of circulating cardiac troponin (hs-cTnT) in apparently healthy individuals. Within normal range, higher levels are associated with coronary atherosclerotic disease (CAD) and cardiac abnormalities commonly associated to traditional risk factors (RFs) for CAD. Therefore, we investigated the relation between circulating hs-cTnT and CAD in patients with a spectrum of RF burden aiming to assess the added value of hs-cTnT to identify outlier patients with CAD in spite of a low RF burden. H s-cTnT was measured in 525 stable patients without previous diagnosis of IHD with 0-1 RF, excluded diabetes, (Low-RF group, n=263) or ≥2 RFs (Multiple-RF group, n=262) and without CAD (segment involvement score, SIS=0) or diffuse CAD (SIS>5) at coronary computed tomography angiography. Outlier patients with diffuse CAD in spite of low RF burden had similar extent, severity and plaque composition than patients with multiple RFs. Overall, hs-cTnT was measurable in 81% of patients with median value of 6.0 ng/L. In both groups, hs-cTnT concentration was higher in patients with CAD than in patients with normal coronary arteries (p6 ng/L) was independently associated with CAD in low-RF group only. D espite very low circulating concentrations, hs-cTnT may identify with a good accuracy the outlier patients with diffuse coronary atherosclerotic disease in spite of low RF burden.
doi_str_mv 10.1016/j.amjcard.2016.02.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1811905642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914916302156</els_id><sourcerecordid>4021682941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-b7c320d3b530944750e52f20467230ba59528b329b8ca3aae1b5392fc45b947d3</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEokvhJ4AsceGS4I98-QKqFkorrVREt2fLcWzWadbe2k6r_SX8XSbsAlIvvdjy-HlnNPNOlr0luCCY1B-HQm4HJUNfUHgWmBYY02fZgrQNzwkn7Hm2wBDKOSn5SfYqxgGehFT1y-yE1rypG04W2a-bqM00Oh0j8gZd2J8bdK1dtMne27RHS6hgpULr4HfeWYfWyPiA0kajy167ZI1VMlnvZvXVlEarA_oOEfiL6MGmDfpijZmiRksfvJNhj85AHXxU43zaiKTr0co_oB823qJzqZIP8XX2wsgx6jfH-zS7Of-6Xl7kq6tvl8uzVa7KlqS8axSjuGddxTAvy6bCuqKG4rJuKMOdrHhF245R3rVKMik1AZJTo8qq42XTs9PswyHvLvi7SccktjYqPY7SaT9FQVpCOK7qkj6NNi2uMCe0BPT9I3TwU3DQyB-qbVnDa6CqA6VgDjFoI3bBbmFCgmAxmywGcTRZzCYLTAU4Crp3x-xTt9X9P9VfVwH4fAA0TO4eHBFRgSFK9zZolUTv7ZMlPj3KoEbrwOrxVu91_N-NiCAQ1_OmzYtGaoYp7Bj7DT8pz9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780883796</pqid></control><display><type>article</type><title>Usefulness of High Sensitivity Cardiac Troponin T for the Identification of Outlier Patients with Diffuse Coronary Atherosclerosis and Low Risk Factors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Magnoni, Marco, MD ; Masson, Serge, PhD ; Andreini, Daniele, MD ; Moccetti, Tiziano, MD ; Modena, Maria Grazia, MD ; Canestrari, Mauro, MD ; Berti, Sergio, MD ; Casolo, Giancarlo, MD ; Gabrielli, Domenico, MD ; Marraccini, Paolo, MD ; Pontone, Gianluca, MD ; Latini, Roberto, MD ; Maggioni, Aldo Pietro, MD ; Maseri, Attilio, MD</creator><creatorcontrib>Magnoni, Marco, MD ; Masson, Serge, PhD ; Andreini, Daniele, MD ; Moccetti, Tiziano, MD ; Modena, Maria Grazia, MD ; Canestrari, Mauro, MD ; Berti, Sergio, MD ; Casolo, Giancarlo, MD ; Gabrielli, Domenico, MD ; Marraccini, Paolo, MD ; Pontone, Gianluca, MD ; Latini, Roberto, MD ; Maggioni, Aldo Pietro, MD ; Maseri, Attilio, MD ; CAPIRE Study Group</creatorcontrib><description>Abstract Novel high sensitivity assay can detect very low levels of circulating cardiac troponin (hs-cTnT) in apparently healthy individuals. Within normal range, higher levels are associated with coronary atherosclerotic disease (CAD) and cardiac abnormalities commonly associated to traditional risk factors (RFs) for CAD. Therefore, we investigated the relation between circulating hs-cTnT and CAD in patients with a spectrum of RF burden aiming to assess the added value of hs-cTnT to identify outlier patients with CAD in spite of a low RF burden. H s-cTnT was measured in 525 stable patients without previous diagnosis of IHD with 0-1 RF, excluded diabetes, (Low-RF group, n=263) or ≥2 RFs (Multiple-RF group, n=262) and without CAD (segment involvement score, SIS=0) or diffuse CAD (SIS&gt;5) at coronary computed tomography angiography. Outlier patients with diffuse CAD in spite of low RF burden had similar extent, severity and plaque composition than patients with multiple RFs. Overall, hs-cTnT was measurable in 81% of patients with median value of 6.0 ng/L. In both groups, hs-cTnT concentration was higher in patients with CAD than in patients with normal coronary arteries (p&lt;0.0001). Hs-cTnT was more accurate to detect patients with CAD in the Low-RF group than in the Multiple-RF group (p=0.04). In multivariate analysis, higher level of hs-cTnT (&gt;6 ng/L) was independently associated with CAD in low-RF group only. D espite very low circulating concentrations, hs-cTnT may identify with a good accuracy the outlier patients with diffuse coronary atherosclerotic disease in spite of low RF burden.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2016.02.002</identifier><identifier>PMID: 26976791</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Aged ; Anxiety ; Atherosclerosis ; Automation ; Biomarkers - blood ; Body Mass Index ; Cardiomyopathy ; Cardiovascular ; Cardiovascular disease ; Cholesterol ; Cholesterol - blood ; Confidence intervals ; Coronary Artery Disease - blood ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - etiology ; Coronary vessels ; Creatinine - blood ; Cross-Sectional Studies ; Diabetes ; Family medical history ; Female ; Heart attacks ; Hospitals ; Humans ; Hypertension ; Laboratories ; Lipoproteins ; Male ; Methods ; Middle Aged ; Predictive Value of Tests ; Regression Analysis ; Risk Factors ; Troponin T - blood ; Values</subject><ispartof>The American journal of cardiology, 2016-05, Vol.117 (9), p.1397-1404</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited May 1, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-b7c320d3b530944750e52f20467230ba59528b329b8ca3aae1b5392fc45b947d3</citedby><cites>FETCH-LOGICAL-c481t-b7c320d3b530944750e52f20467230ba59528b329b8ca3aae1b5392fc45b947d3</cites><orcidid>0000-0003-3094-9391 ; 0000-0003-3392-0527 ; 0000-0002-1446-0281</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914916302156$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26976791$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Magnoni, Marco, MD</creatorcontrib><creatorcontrib>Masson, Serge, PhD</creatorcontrib><creatorcontrib>Andreini, Daniele, MD</creatorcontrib><creatorcontrib>Moccetti, Tiziano, MD</creatorcontrib><creatorcontrib>Modena, Maria Grazia, MD</creatorcontrib><creatorcontrib>Canestrari, Mauro, MD</creatorcontrib><creatorcontrib>Berti, Sergio, MD</creatorcontrib><creatorcontrib>Casolo, Giancarlo, MD</creatorcontrib><creatorcontrib>Gabrielli, Domenico, MD</creatorcontrib><creatorcontrib>Marraccini, Paolo, MD</creatorcontrib><creatorcontrib>Pontone, Gianluca, MD</creatorcontrib><creatorcontrib>Latini, Roberto, MD</creatorcontrib><creatorcontrib>Maggioni, Aldo Pietro, MD</creatorcontrib><creatorcontrib>Maseri, Attilio, MD</creatorcontrib><creatorcontrib>CAPIRE Study Group</creatorcontrib><title>Usefulness of High Sensitivity Cardiac Troponin T for the Identification of Outlier Patients with Diffuse Coronary Atherosclerosis and Low Risk Factors</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Abstract Novel high sensitivity assay can detect very low levels of circulating cardiac troponin (hs-cTnT) in apparently healthy individuals. Within normal range, higher levels are associated with coronary atherosclerotic disease (CAD) and cardiac abnormalities commonly associated to traditional risk factors (RFs) for CAD. Therefore, we investigated the relation between circulating hs-cTnT and CAD in patients with a spectrum of RF burden aiming to assess the added value of hs-cTnT to identify outlier patients with CAD in spite of a low RF burden. H s-cTnT was measured in 525 stable patients without previous diagnosis of IHD with 0-1 RF, excluded diabetes, (Low-RF group, n=263) or ≥2 RFs (Multiple-RF group, n=262) and without CAD (segment involvement score, SIS=0) or diffuse CAD (SIS&gt;5) at coronary computed tomography angiography. Outlier patients with diffuse CAD in spite of low RF burden had similar extent, severity and plaque composition than patients with multiple RFs. Overall, hs-cTnT was measurable in 81% of patients with median value of 6.0 ng/L. In both groups, hs-cTnT concentration was higher in patients with CAD than in patients with normal coronary arteries (p&lt;0.0001). Hs-cTnT was more accurate to detect patients with CAD in the Low-RF group than in the Multiple-RF group (p=0.04). In multivariate analysis, higher level of hs-cTnT (&gt;6 ng/L) was independently associated with CAD in low-RF group only. D espite very low circulating concentrations, hs-cTnT may identify with a good accuracy the outlier patients with diffuse coronary atherosclerotic disease in spite of low RF burden.</description><subject>Acute coronary syndromes</subject><subject>Aged</subject><subject>Anxiety</subject><subject>Atherosclerosis</subject><subject>Automation</subject><subject>Biomarkers - blood</subject><subject>Body Mass Index</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Cholesterol</subject><subject>Cholesterol - blood</subject><subject>Confidence intervals</subject><subject>Coronary Artery Disease - blood</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - etiology</subject><subject>Coronary vessels</subject><subject>Creatinine - blood</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Family medical history</subject><subject>Female</subject><subject>Heart attacks</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Laboratories</subject><subject>Lipoproteins</subject><subject>Male</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Regression Analysis</subject><subject>Risk Factors</subject><subject>Troponin T - blood</subject><subject>Values</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkk1v1DAQhiMEokvhJ4AsceGS4I98-QKqFkorrVREt2fLcWzWadbe2k6r_SX8XSbsAlIvvdjy-HlnNPNOlr0luCCY1B-HQm4HJUNfUHgWmBYY02fZgrQNzwkn7Hm2wBDKOSn5SfYqxgGehFT1y-yE1rypG04W2a-bqM00Oh0j8gZd2J8bdK1dtMne27RHS6hgpULr4HfeWYfWyPiA0kajy167ZI1VMlnvZvXVlEarA_oOEfiL6MGmDfpijZmiRksfvJNhj85AHXxU43zaiKTr0co_oB823qJzqZIP8XX2wsgx6jfH-zS7Of-6Xl7kq6tvl8uzVa7KlqS8axSjuGddxTAvy6bCuqKG4rJuKMOdrHhF245R3rVKMik1AZJTo8qq42XTs9PswyHvLvi7SccktjYqPY7SaT9FQVpCOK7qkj6NNi2uMCe0BPT9I3TwU3DQyB-qbVnDa6CqA6VgDjFoI3bBbmFCgmAxmywGcTRZzCYLTAU4Crp3x-xTt9X9P9VfVwH4fAA0TO4eHBFRgSFK9zZolUTv7ZMlPj3KoEbrwOrxVu91_N-NiCAQ1_OmzYtGaoYp7Bj7DT8pz9A</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Magnoni, Marco, MD</creator><creator>Masson, Serge, PhD</creator><creator>Andreini, Daniele, MD</creator><creator>Moccetti, Tiziano, MD</creator><creator>Modena, Maria Grazia, MD</creator><creator>Canestrari, Mauro, MD</creator><creator>Berti, Sergio, MD</creator><creator>Casolo, Giancarlo, MD</creator><creator>Gabrielli, Domenico, MD</creator><creator>Marraccini, Paolo, MD</creator><creator>Pontone, Gianluca, MD</creator><creator>Latini, Roberto, MD</creator><creator>Maggioni, Aldo Pietro, MD</creator><creator>Maseri, Attilio, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3094-9391</orcidid><orcidid>https://orcid.org/0000-0003-3392-0527</orcidid><orcidid>https://orcid.org/0000-0002-1446-0281</orcidid></search><sort><creationdate>20160501</creationdate><title>Usefulness of High Sensitivity Cardiac Troponin T for the Identification of Outlier Patients with Diffuse Coronary Atherosclerosis and Low Risk Factors</title><author>Magnoni, Marco, MD ; Masson, Serge, PhD ; Andreini, Daniele, MD ; Moccetti, Tiziano, MD ; Modena, Maria Grazia, MD ; Canestrari, Mauro, MD ; Berti, Sergio, MD ; Casolo, Giancarlo, MD ; Gabrielli, Domenico, MD ; Marraccini, Paolo, MD ; Pontone, Gianluca, MD ; Latini, Roberto, MD ; Maggioni, Aldo Pietro, MD ; Maseri, Attilio, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-b7c320d3b530944750e52f20467230ba59528b329b8ca3aae1b5392fc45b947d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute coronary syndromes</topic><topic>Aged</topic><topic>Anxiety</topic><topic>Atherosclerosis</topic><topic>Automation</topic><topic>Biomarkers - blood</topic><topic>Body Mass Index</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Cholesterol</topic><topic>Cholesterol - blood</topic><topic>Confidence intervals</topic><topic>Coronary Artery Disease - blood</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - etiology</topic><topic>Coronary vessels</topic><topic>Creatinine - blood</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Family medical history</topic><topic>Female</topic><topic>Heart attacks</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Laboratories</topic><topic>Lipoproteins</topic><topic>Male</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Regression Analysis</topic><topic>Risk Factors</topic><topic>Troponin T - blood</topic><topic>Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Magnoni, Marco, MD</creatorcontrib><creatorcontrib>Masson, Serge, PhD</creatorcontrib><creatorcontrib>Andreini, Daniele, MD</creatorcontrib><creatorcontrib>Moccetti, Tiziano, MD</creatorcontrib><creatorcontrib>Modena, Maria Grazia, MD</creatorcontrib><creatorcontrib>Canestrari, Mauro, MD</creatorcontrib><creatorcontrib>Berti, Sergio, MD</creatorcontrib><creatorcontrib>Casolo, Giancarlo, MD</creatorcontrib><creatorcontrib>Gabrielli, Domenico, MD</creatorcontrib><creatorcontrib>Marraccini, Paolo, MD</creatorcontrib><creatorcontrib>Pontone, Gianluca, MD</creatorcontrib><creatorcontrib>Latini, Roberto, MD</creatorcontrib><creatorcontrib>Maggioni, Aldo Pietro, MD</creatorcontrib><creatorcontrib>Maseri, Attilio, MD</creatorcontrib><creatorcontrib>CAPIRE Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Magnoni, Marco, MD</au><au>Masson, Serge, PhD</au><au>Andreini, Daniele, MD</au><au>Moccetti, Tiziano, MD</au><au>Modena, Maria Grazia, MD</au><au>Canestrari, Mauro, MD</au><au>Berti, Sergio, MD</au><au>Casolo, Giancarlo, MD</au><au>Gabrielli, Domenico, MD</au><au>Marraccini, Paolo, MD</au><au>Pontone, Gianluca, MD</au><au>Latini, Roberto, MD</au><au>Maggioni, Aldo Pietro, MD</au><au>Maseri, Attilio, MD</au><aucorp>CAPIRE Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of High Sensitivity Cardiac Troponin T for the Identification of Outlier Patients with Diffuse Coronary Atherosclerosis and Low Risk Factors</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>117</volume><issue>9</issue><spage>1397</spage><epage>1404</epage><pages>1397-1404</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Abstract Novel high sensitivity assay can detect very low levels of circulating cardiac troponin (hs-cTnT) in apparently healthy individuals. Within normal range, higher levels are associated with coronary atherosclerotic disease (CAD) and cardiac abnormalities commonly associated to traditional risk factors (RFs) for CAD. Therefore, we investigated the relation between circulating hs-cTnT and CAD in patients with a spectrum of RF burden aiming to assess the added value of hs-cTnT to identify outlier patients with CAD in spite of a low RF burden. H s-cTnT was measured in 525 stable patients without previous diagnosis of IHD with 0-1 RF, excluded diabetes, (Low-RF group, n=263) or ≥2 RFs (Multiple-RF group, n=262) and without CAD (segment involvement score, SIS=0) or diffuse CAD (SIS&gt;5) at coronary computed tomography angiography. Outlier patients with diffuse CAD in spite of low RF burden had similar extent, severity and plaque composition than patients with multiple RFs. Overall, hs-cTnT was measurable in 81% of patients with median value of 6.0 ng/L. In both groups, hs-cTnT concentration was higher in patients with CAD than in patients with normal coronary arteries (p&lt;0.0001). Hs-cTnT was more accurate to detect patients with CAD in the Low-RF group than in the Multiple-RF group (p=0.04). In multivariate analysis, higher level of hs-cTnT (&gt;6 ng/L) was independently associated with CAD in low-RF group only. D espite very low circulating concentrations, hs-cTnT may identify with a good accuracy the outlier patients with diffuse coronary atherosclerotic disease in spite of low RF burden.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26976791</pmid><doi>10.1016/j.amjcard.2016.02.002</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3094-9391</orcidid><orcidid>https://orcid.org/0000-0003-3392-0527</orcidid><orcidid>https://orcid.org/0000-0002-1446-0281</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2016-05, Vol.117 (9), p.1397-1404
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1811905642
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute coronary syndromes
Aged
Anxiety
Atherosclerosis
Automation
Biomarkers - blood
Body Mass Index
Cardiomyopathy
Cardiovascular
Cardiovascular disease
Cholesterol
Cholesterol - blood
Confidence intervals
Coronary Artery Disease - blood
Coronary Artery Disease - diagnosis
Coronary Artery Disease - etiology
Coronary vessels
Creatinine - blood
Cross-Sectional Studies
Diabetes
Family medical history
Female
Heart attacks
Hospitals
Humans
Hypertension
Laboratories
Lipoproteins
Male
Methods
Middle Aged
Predictive Value of Tests
Regression Analysis
Risk Factors
Troponin T - blood
Values
title Usefulness of High Sensitivity Cardiac Troponin T for the Identification of Outlier Patients with Diffuse Coronary Atherosclerosis and Low Risk Factors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A26%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20High%20Sensitivity%20Cardiac%20Troponin%20T%20for%20the%20Identification%20of%20Outlier%20Patients%20with%20Diffuse%20Coronary%20Atherosclerosis%20and%20Low%20Risk%20Factors&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Magnoni,%20Marco,%20MD&rft.aucorp=CAPIRE%20Study%20Group&rft.date=2016-05-01&rft.volume=117&rft.issue=9&rft.spage=1397&rft.epage=1404&rft.pages=1397-1404&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2016.02.002&rft_dat=%3Cproquest_cross%3E4021682941%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780883796&rft_id=info:pmid/26976791&rft_els_id=S0002914916302156&rfr_iscdi=true